跳至主要内容
临床试验/TCTR20190609001
TCTR20190609001招募中2 期

HBsAg seroclearance in non-cirrhotic, HBeAg-negative chronic hepatitis B patients who discontinue tenofovir or entecavir, prospective cohort study

Faculty of Medicine Siriraj Hospital0 个研究点目标入组 420 人开始时间: 2019年6月9日最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
入组人数
420

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 100 Years(—)
性别
All

入选标准

  • 1. Age > 18 years old
  • 2. Chronic hepatitis B eAg negative (ตั้งแต่แรกวินิจฉัย)
  • 3. On treatment of TDF or ETV at least 3 years
  • 4. HBV DNA < 10 IU/ml at least 2 years before enrollment
  • 5. No evidence of advanced fibrosis (Liver biopsy METAVIR > F3 )
  • 6. No history of hepatic decompensation
  • 7. CTP A (serum total bilirubin <2 mg/dl, serum albumin>3.5 mg/dl, INR <1.7)
  • 8. CBC: Hemoglobin > 12 gm/dL, platelets > 100,000 mm3

排除标准

  • 1. Transient elastography > 10 at least 6 months before enrollment
  • 2. Creatinine clearance < 50
  • 3. Poor compliance
  • 4. Co-existing hepatocellular carcinoma or others malignancy
  • 5. Co-existing with HIV or HCV infection
  • 6. Pregnancy or breast feeding
  • 7. Diagnosis of chronic liver disease from others etiology eg. AIH , Alcoholic liver disease
  • 8.On immunosuppresive drugs or Post organ transplant

研究者

相似试验